Arik Hanannel
Co-Founder & CEO
Claimed by owner FUSMobile
Former names:
Focused Ultrasound Therapy for Chronic Pain
FUSMobile
www.israel21c.org
•
May 12, 2019
9 emerging devices that will disrupt health care
www.fusfoundation.org
•
Oct 18, 2017
Clinical Trial Begins in Canada for Facet Arthritis Low Back Pain
blogs.biomedcentral.com
•
Aug 29, 2016
High Intensity Focused Ultrasound: A novel and non-invasive approach to target tumors - On Medicine
About
FUSMobile advances noninvasive solutions for chronic painful conditions in order to improve the patient experience and clinical outcomes while reducing costs for healthcare providers and payers.
The companys Neurolyser is a focused ultrasound treatment platform designed to relieve the suffering caused by a range of common conditions, including chronic lower back (facet joint) pain, knee and hip arthritis, sacroiliitis, and bone metastases. The completely noninvasive solution thermally ablates nerves without the risks, pain, high costs, and extensive training required by more invasive methods.
FUSMobiles Neurolyser XR focused ultrasound device has finished its first-in-human study with excellent results and will soon enter pivotal clinical trials in pursuit of North American regulatory approval for facet joint arthritis, the first of many pain-related indications with potential benefits over currently available interventional pain treatments.
The companys Neurolyser is a focused ultrasound treatment platform designed to relieve the suffering caused by a range of common conditions, including chronic lower back (facet joint) pain, knee and hip arthritis, sacroiliitis, and bone metastases. The completely noninvasive solution thermally ablates nerves without the risks, pain, high costs, and extensive training required by more invasive methods.
FUSMobiles Neurolyser XR focused ultrasound device has finished its first-in-human study with excellent results and will soon enter pivotal clinical trials in pursuit of North American regulatory approval for facet joint arthritis, the first of many pain-related indications with potential benefits over currently available interventional pain treatments.
Employees
Product stage
Primary Sector
Life Sciences & HealthTech
Products
Neurolyser
Geographic markets
Global
Funding
Total Funding
Undisclosed
Last Funding
Undisclosed
Funding Stage
Total Rounds
1
Investors
1
News
(3)
www.israel21c.org
•
May 12, 2019
9 emerging devices that will disrupt health care
www.fusfoundation.org
•
Oct 18, 2017
Clinical Trial Begins in Canada for Facet Arthritis Low Back Pain
blogs.biomedcentral.com
•
Aug 29, 2016
High Intensity Focused Ultrasound: A novel and non-invasive approach to target tumors - On Medicine
The Team
(2)
AH
RA
Ron Aginsky
Co-founder & President
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Private Equity Funding
Undisclosed Round
Undisclosed
Jul 2017
1 Investors
Undisclosed
Media gallery
(1)
Locations
Israel
Sderot HaNadiv 5, Haifa, Israel
Offices Abroad
2972 Webb Bridge Rd, Alpharetta, GA, USA
Locations
Israel
Sderot HaNadiv 5, Haifa, Israel
Offices Abroad
2972 Webb Bridge Rd, Alpharetta, GA, USA
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,